A new generative AI model predicts the risk and timing of over 1,000 diseases using large-scale health record data from the UK and Denmark.
Key Details
- 1The model was trained on anonymised data from 400,000 UK Biobank participants and validated on 1.9 million Danish registry patients.
- 2It leverages generative transformer techniques similar to those in large language models to process health event sequences.
- 3Excels at forecasting diseases with clear progression patterns (e.g., heart attacks, cancer); less effective for variable conditions.
- 4Produces probabilistic, population-level risk estimates rather than individual certainties; shorter-term forecasts are more reliable.
- 5Underrepresents childhood/adolescent events and some ethnic groups due to training data limitations.
- 6Not yet ready for clinical use, but helps study disease progression and simulate outcomes for research.
Why It Matters
This research demonstrates the growing potential of AI to model disease trajectories at scale, paving the way for more preventive, personalized medicine. While not clinic-ready, such approaches could support risk stratification, resource planning, and ultimately improve patient outcomes in radiology and beyond.
Source
EurekAlert
Related News
•EurekAlert
AI Tool from UCLA Targets Undiagnosed Alzheimer's and Diagnostic Disparity
UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.
•EurekAlert
AI Multimodal Models Improve Breast Cancer Recurrence Risk Prediction
Initial results from an ECOG-ACRIN and Caris Life Sciences collaboration show AI-driven multimodal models can more accurately predict recurrence risk in early-stage breast cancer.
•EurekAlert
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.